Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy. - Wikidata - awgldk - TriplyDB

Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.

Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.

http://www.wikidata.org/entity/Q37029108

about

Oxidative stress in schizophrenia Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients.Decreased 16:0/20:4-phosphatidylinositol level in the post-mortem prefrontal cortex of elderly patients with schizophrenia.The effect of clozapine on the AMPK-ACC-CPT1 pathway in the rat frontal cortex.

P2860

Q24595660-D40E7D9A-9392-4695-ADDC-F6E81F57FA20 Q35907531-53B3868C-B6BE-4022-B2A3-9E65F7707FF3 Q36750552-E45697FB-31FE-45B9-8859-071964F6C1A7 Q37717294-ECF026BC-54A2-4B42-816A-93D7C2E45632 Q49083919-56BE384A-9441-47BF-96F6-D1E9662F0693

P2860

Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.

http://www.wikidata.org/entity/Q37029108

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.

@en

Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.

@nl

type

label

Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.

@en

Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.

@nl

prefLabel

Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.

@en

Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.

@nl

P1433

Q37029108-B720C6B0-FB56-403C-AAC6-AADD5421244F

P1476

Q37029108-6F0E6759-0978-48B6-82EA-025A1133D051

P2093

Q37029108-1CD76526-342C-4642-ADB1-61C2087C739D

Q37029108-C89F6F6C-0622-4225-AECD-61CC7F4FB041

Q37029108-F8CBD3FA-2633-466B-A714-F732043FD670

P2860

Q37029108-02AA607C-2CEF-4A3E-A9E6-43055EEA969B

Q37029108-087084E0-AC9F-4D42-B3E9-B13142D146F7

Q37029108-23B04EB3-40A0-4661-9252-098DB4ACB709

Q37029108-2C8DA80D-8120-4D9F-9522-A4F568912DAF

Q37029108-32F567D5-F16F-403B-89E6-4FC1C26FE2B9

Q37029108-33AEB483-2E65-4DDA-B440-8BF62305776C

Q37029108-3588BE13-0574-4DD5-B15A-9F05FF08D699

Q37029108-35C933CB-F7DB-4C55-8FE6-C314FE419267

Q37029108-3BE204CB-A10E-4FA9-B4B6-C0764017D164

Q37029108-5374461D-0B8A-4322-AF47-C679959870F9

P304

Q37029108-B410B09E-A556-4E0E-B423-72A69AF03F05

P31

Q37029108-98D9BFB0-00BA-430E-8F9F-48CF7A46787B

P356

Q37029108-72D41FA8-8485-4484-9420-83FE83262B2A

P433

Q37029108-FB11E9B6-390D-435A-AC95-629E6E1D1CE1

P478

Q37029108-2ECE71A7-7E40-4052-B0FB-57DD2E56EF53

P577

Q37029108-E7856930-B568-4889-AAD0-DC8807FA4E72

P5875

Q37029108-74963106-BE2C-4B32-9F54-24AE5974CDEF

P698

Q37029108-05DCB5C6-9AF6-4509-A31A-B63FE3C8CCFF

P921

Q37029108-13BC1225-9A2B-4C9F-9007-6A99CFAAE8AC

P932

Q37029108-4950EC2A-BBBE-40FF-809F-0E472BD1A4BC

P356

P1433

Magnetic Resonance in Medicine

P1476

Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.

@en

P2093

John M Pearce

http://www.w3.org/2001/XMLSchema#string

Richard A Komoroski

http://www.w3.org/2001/XMLSchema#string

Robert E Mrak

http://www.w3.org/2001/XMLSchema#string

P2860

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia.

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia.

Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder.

Diagnostic criteria for use in psychiatric research.

Choline acetyltransferase in schizophrenia.

The human brain revisited: opportunities and challenges in postmortem studies of psychiatric disorders.

Metabolomic mapping of atypical antipsychotic effects in schizophrenia.

Lipid composition of the normal human brain: gray matter, white matter, and myelin.

Is schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implications.

P304

28-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MRM.21820

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23678123

http://www.w3.org/2001/XMLSchema#string

P698

19097198

http://www.w3.org/2001/XMLSchema#string

P921

P932

2610237

http://www.w3.org/2001/XMLSchema#string